OQS
ALXO icon

Occudo Quantitative Strategies’s ALX Oncology ALXO Stock Holding History

Occudo Quantitative Strategies’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,003
Closed -$43.7K – 663
2024
Q3 		$43.7K Buy
24,003
+7,601
+46% +$28.3K 0.01% 666
2024
Q2 		$98.9K Buy
+16,402
New +$202K 0.02% 664
2022
Q4 		– Sell
-23,332
Closed -$223K – 936
2022
Q3 		$223K Sell
23,332
-49,617
-68% -$578K 0.02% 939
2022
Q2 		$590K Buy
72,949
+29,401
+68% +$320K 0.05% 560
2022
Q1 		$736K Buy
43,548
+11,439
+36% +$195K 0.06% 490
2021
Q4 		$690K Buy
+32,109
New +$1.38M 0.06% 491

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Occudo Quantitative Strategies's ALXO Position: Q4 2024 in Review

Occudo Quantitative Strategies sold out of ALX Oncology (ALXO) in Q4 2024, closing a stake of 24,003 shares — an estimated $43.7K sold.

Occudo Quantitative Strategies first reported a position in ALXO in Q4 2021 and held it in 6 quarters. The position peaked at $736K in Q1 2022. 87 funds tracked by Wall St. Rank hold ALXO as of Q4 2024.

  • Occudo Quantitative Strategies reported no remaining ALX Oncology position as of Q4 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 24,003 ALX Oncology shares in Q4 2024, an estimated $43.7K.
  • Occudo Quantitative Strategies first reported a position in ALX Oncology in Q4 2021 and held it in 6 quarters.
  • Occudo Quantitative Strategies's ALX Oncology position peaked at $736K in Q1 2022.
  • 87 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.